Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation

Published:2018-05-15 Issue:6 Volume:109 Page:1853-1864
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sun Si¹,Zhao Simei¹,Yang Qiang¹,Wang Wenwen¹,Cai E¹,Wen Yiping¹,Yu Lili¹,Wang Zehua¹^ORCID,Cai Jing¹

Affiliation:

1. Department of Obstetrics and Gynecology; Union Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13599/fullpdf

Reference46 articles.

1. BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma;Beale;Br J Cancer,2000

2. Oxaliplatin for the treatment of ovarian cancer;Bogliolo;Expert Opin Investig Drugs,2015

3. Systems biology of cisplatin resistance: past, present and future;Galluzzi;Cell Death Dis,2014

4. Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator;Ishida;Cancer Cell,2010

5. Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer;Kim;Lung Cancer,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis;BMC Cancer;2024-04-22

2. Drug resistance in ovarian cancer: from mechanism to clinical trial;Molecular Cancer;2024-03-28

3. Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress;Cancer Discovery;2024-02-16

4. Epigenetic Alterations as an Adaptive Response to Chemotherapy;Drug Resistance in Cancer: Mechanisms and Strategies;2024

5. p27 Kip1 and cytoplasmic pSer10p27 are promising biomarkers for predicting prognosis and chemotherapy response in ovarian cancer;2023-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3